CARETEQ LIMITED — Proxy Solicitation & Information Statement 2026

Mar 23, 2026

==> picture [208 x 70] intentionally omitted <==

CARETEQ LIMITED ACN 612 267 857

Notice of General Meeting Explanatory Memorandum & Proxy Form

Notice is given that the Meeting will be held at:

DATE: Thursday 23 April 2026 TIME: 9.00AM (AEST) VENUE: Held as a Virtual Meeting

The business of Meeting affects your shareholding and your vote is important.

This Notice of Meeting should be read in its entirety. If Shareholders are in doubt as to how they should vote, they should seek advice from their professional advisers prior to voting.

Page 1

Careteq Limited - 2026 Notice of GM #11058870v1

==> picture [208 x 70] intentionally omitted <==

CARETEQ LIMITED

Notice of General Meeting

Notice is given that the General Meeting ( GM or Meeting or General Meeting ) of the Shareholders of Careteq Limited (ACN 612 267 857) ( Careteq or the Company ) will be held on Thursday 23 April 2026 at 9.00am (AEST) virtually.

Shareholders are strongly encouraged to submit their proxies as early as possible and in any event prior to the cutoff for proxy voting as set out in the Notice. To lodge your proxy, please follow the directions on your personalised proxy form which will be enclosed with a copy of the Notice, delivered to you by email or post (depending on your communication preferences). If a Shareholder has nominated for electronic communications, they will receive the Notice by email. Other Shareholders will receive a postcard with a URL link to the Notice and Proxy Form.

VENUE AND VOTING INFORMATION

The company is pleased to provide shareholders with the opportunity to attend and participate in a virtual Meeting through an online meeting platform powered by Automic.

Shareholders that have an existing account with Automic will be able to watch, listen and vote online.

Shareholders who do not have an account with Automic are strongly encouraged to register for an account as soon as possible and well in advance of the Meeting to avoid any delays on the day of the Meeting.

An account can be created via the following link investor.automic.com.au and then clicking on “ register ” and following the prompts. Shareholders will require their holder number (Securityholder Reference Number (SRN) or Holder Identification Number (HIN)) to create an account with Automic.

To access the virtual meeting on the day:

1. Open your internet browser and go to investor.automic.com.au

2. Login with your username and password or click “ register ” if you haven’t already created an account. Shareholders are encouraged to create an account prior to the start of the meeting to ensure there is no delay in attending the virtual meeting

3. After logging in, a banner will display at the bottom of your screen to indicate that the meeting is open for registration, click on “ Register ” when this appears. Alternatively, click on “ Meetings ” on the left-hand menu bar to join the meeting.

4. Click on “ Join Meeting ” and follow the prompts om screen to register and vote.

Shareholders will be able to vote (see the “Voting virtually at the Meeting” section of this Notice of Meeting below) and ask questions at the virtual meeting.

Shareholders are also encouraged to submit questions in advance of the Meeting to the Company.

Questions must be submitted in writing to info@careteq.com.au at least 48 hours before the GM

The Company will also provide Shareholders with the opportunity to ask questions during the Meeting in respect to the formal items of business as well as general questions in respect to the Company and its business.

Voting virtually at the Meeting

Shareholders who wish to vote virtually on the day of the GM can do so by logging in to the Automic shareholder portal.

1. Open your internet browser and go to investor.automic.com.au

2. Login using your username and password. If you do not already have an account, click “ Register ” and follow the prompts. Shareholders are encouraged to register prior to the commencement of the Meeting to avoid delays in accessing the virtual platform.

3. After logging in, a banner will appear at the bottom of your screen when the Meeting is open for registration. Click “ Register” . Alternatively, select Meetings from the left-hand menu.

4. Click on “ Join Meeting ” and follow the prompts.

5. When the Chair of the Meeting declares the poll open, select the “ Voting ” dropdown menu on the righthand side of your screen.

Page 2

Careteq Limited - 2026 Notice of GM

==> picture [208 x 70] intentionally omitted <==

1. Select either the “ Full ” or “ Allocate ” option to access your electronic voting card.

7. Follow the prompts to record your voting direction for each resolution and click “ Submit votes ”. For allocated votes, the number of votes submitted must not exceed your remaining available units. Important : Votes cannot be amended once submitted.

For further information on the live voting process please see the Registration and Voting Guide at https://www.automicgroup.com.au/virtual-GMs/

It is recommended that Shareholders wishing to attend the Meeting login 15 mins before the meeting on 23 April 2026.

Shareholders do not need to attend the Meeting to cast their vote/s and are encouraged to submit their votes and appoint the Chairperson as their proxy. Detailed instructions for lodging votes and appointment of a proxy are included in the accompanying Notice of Meeting and Proxy Form.

Voting on all Resolutions at the Meeting will be conducted by poll.

VOTING ELIGIBILITY

The Directors have determined pursuant to Regulation 7.11.37 of the Corporations Act 2001 (Cth) that the persons eligible to vote at the Meeting are those who are registered Shareholders at 9.00am AEST on 21 April 2026.

If you have any queries on how to cast your votes, please email Automic at: meetings@automicgroup.com.au.

VOTING BY ATTORNEY

Shareholders intending to attend the Meeting by attorney must ensure that they have provided the original or a certified copy of the power of attorney to the Company, in the same manner prescribed below for the giving of proxy forms to the Company.

VOTING BY PROXY

To vote by proxy, please complete and sign the enclosed Proxy Form and return by the time and in accordance with the instructions set out on the Proxy Form.

In accordance with section 249L of the Corporations Act, Shareholders are advised that:

• each Shareholder has a right to appoint a proxy;

• the proxy need not be a Shareholder; and

• a Shareholder who is entitled to cast two or more votes may appoint two proxies and may specify the proportion or number of votes each proxy is appointed to exercise. If the member appoints two proxies and the appointment does not specify the proportion or number of the member’s votes, then in accordance with section 249X(3) of the Corporations Act, each proxy may exercise one-half of the votes.

Proxy vote if appointment specifies way to vote

Section 250BB(1) of the Corporations Act provides that an appointment of a proxy may specify the way the proxy is to vote on a particular Resolution. If an appointment of a proxy specifies the way the proxy is to vote on a particular Resolution:

• The proxy need not vote on a show of hands, but if the proxy does so, the proxy must vote that way (i.e. as directed); and

• If the proxy has two or more appointments that specify different ways to vote on the Resolution, the proxy must not vote on a show of hands; and

• If the proxy is the Chair at which the Resolution is voted on, the proxy must vote on a poll, and must vote that way (i.e. as directed); and

• If the proxy is not the Chair, the proxy need not vote on the poll, but if the proxy does so, the proxy must vote that way (i.e. as directed); and

Page 3

Careteq Limited - 2026 Notice of GM

==> picture [208 x 70] intentionally omitted <==

If the proxy is not the Chair and at the Meeting, a poll is duly demanded on the Resolution and either of the following applies:

• the proxy is not recorded as attending the Meeting; or

• the proxy does not vote on the Resolution,

the Chair is taken, before voting on the Resolution closes, to have been appointed as the proxy for the purposes of voting on the Resolution of the Meeting.

If you appoint the Chair of the Meeting as your proxy, you can direct the Chair to vote for or against or abstain from voting on the Resolutions.

The Chair intends to vote undirected proxies in favour of Resolutions 1-3.

CORPORATE REPRESENTATIVES

A Shareholder that is a body corporate may appoint an individual to act as its representative at the Meeting by providing a duly executed Certificate of Appointment of Corporate Representative (Certificate). Unless otherwise specified in the Certificate, the representative may exercise all or any of the powers that the body corporate may exercise at the Meeting or in voting on a Resolution. A Certificate is available upon request from Automic.

Certificates must be lodged in advance of the Meeting with Automic no less than 24 hours prior to the Meeting.

QUESTIONS AND COMMENTS BY SHAREHOLDERS AT THE GENERAL MEETING

In accordance with the Corporations Act, a reasonable opportunity will be given to Shareholders to ask questions about or make comments on the management of the Company at the Meeting.

Shareholders may submit any written questions addressed to the Company or its external auditor via the address on the proxy form or to Careteq Limited via email at info@careteq.com.au no later than 48 hours prior to the Meeting.

The Company will either answer the questions at the Meeting or table written answers to them at the Meeting. If written answers are tabled at the Meeting, they will be made available to Shareholders as soon as practicable after the Meeting.

Shareholders may also submit questions to the Board related to any of the resolutions to be considered. These questions will be responded to by the Board during the Meeting. As above, questions should be submitted to info@careteq.com.au no later than 48 hours prior to the Meeting.

TECHNICAL DIFFICULTIES

Technical difficulties may arise during the course of the General Meeting. The Chair has discretion as to whether and how the Meeting should proceed in the event that a technical difficulty arises. In exercising his discretion, the Chair will have regard to the number of Shareholders impacted and the extent to which participation in the business of the Meeting is affected. Where he considers it appropriate, the Chair may continue to hold the Meeting and transact business, including conducting a poll and voting in accordance with valid proxy instructions. For this reason, Shareholders are encouraged to lodge a proxy not later than 48 hours before the commencement of the Meeting.

ENQUIRIES

Shareholders are asked to contact the Company at info@careteq.com.au or the Company Secretary at david.lilja@dlkadvisory.com.au or on +61 3 9923 1222 if they have any queries in respect of the matters set out in these documents.

Page 4

Careteq Limited - 2026 Notice of GM

==> picture [208 x 70] intentionally omitted <==

CARETEQ LIMITED

Notice of General Meeting

Notice is given that the General Meeting of the Shareholders of Careteq Limited (ACN 612 267 857) (Careteq or the Company) will be held on Thursday 23 April 2026 at 9.00am (AEST) virtually.

The Explanatory Memorandum to this Notice of Meeting ( Notice ) provides additional information on matters to be considered at the General Meeting. The Explanatory Memorandum and the Proxy Form are part of this Notice.

ORDINARY BUSINESS

RESOLUTION 1 – RATIFICATION OF PRIOR ISSUE OF 38,632,636 TRANCHE 1 PLACEMENT SHARES

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of ASX Listing Rule 7.4 and for all other purposes, Shareholders ratify the issue of 38,632,636 Tranche 1 Placement Shares, on the terms and conditions specified in the Explanatory Memorandum which accompanies and forms part of this Notice.”

A voting exclusion statement applies to this Resolution.

RESOLUTION 2 – APPROVAL TO ISSUE 401,367,364 TRANCHE 2 PLACEMENT SHARES

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of ASX Listing Rule 7.1 and for all other purposes, Shareholders approve the issue of 401,367,364 Tranche 2 Placement Shares, on the terms and conditions specified in the Explanatory Memorandum which accompanies and forms part of this Notice.”

A voting exclusion statement applies to this Resolution.

RESOLUTION 3 – APPROVAL TO ISSUE 50,000,000 ADVISOR OPTIONS

To consider and, if thought fit, to pass, with or without amendment, the following resolution as an ordinary resolution :

“That, for the purposes of ASX Listing Rule 7.1 and for all other purposes, Shareholders approve the issue of 50,000,000 Advisor Options, on the terms and conditions specified in the Explanatory Memorandum which accompanies and forms part of this Notice.”

A voting exclusion statement applies to this Resolution.

Page 5

Careteq Limited - 2026 Notice of GM

==> picture [208 x 70] intentionally omitted <==

VOTING EXCLUSIONS

1. Under the Corporations Act and ASX Listing Rule 14.11, the Company will disregard any votes cast in favour of the resolutions by or on behalf of:

2. the names person or class of persons excluded from voting as set out in the Explanatory Statement; or

3. an associate of that person or those persons.

However, this does not apply to a vote cast in favour of a resolution by:

• a person as a proxy or attorney for a person who is entitled to vote on the resolution, in accordance with directions given to the proxy or attorney to vote on the resolution in that way; or

• the chair of the meeting as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with a direction given to the chair to vote on the resolution as the chair decides; or

• a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met.

  • the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of the person excluded from voting, on the resolution; and

  • the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

• KMP that may have a vested interest in the outcome of a Resolution have restrictions on voting on those Resolutions. KMP include members of the Board and certain senior executives, as set out in the RNV Annual Report. The Corporations Act restricts KMP and their Closely Related Parties from voting in certain circumstances.

• Under the Corporations and ASX Listing Rules, voting exclusions apply to the following Resolutions and further detail is provided in the Explanatory Statement:

• Resolution 1 – Ratification of Prior Issue of 38,632,636 Tranche 1 Placement Shares;

• Resolution 2 – Approval to Issue 401,367,364 Tranche 2 Placement Shares; and

• Resolution 3 – Approval to Issue 50,000,000 Advisor Options.

DATE: 24 March 2026

BY ORDER OF THE BOARD

==> picture [83 x 52] intentionally omitted <==

DAVID LILJA

COMPANY SECRETARY

Page 6

Careteq Limited - 2026 Notice of GM

==> picture [208 x 70] intentionally omitted <==

EXPLANATORY MEMORANDUM

This Explanatory Memorandum has been prepared to provide information which the Directors believe to be material to Shareholders in deciding whether or not to pass the Resolutions.

RESOLUTION 1 – RATIFICATION OF PRIOR ISSUE OF 38,632,636 TRANCHE 1 PLACEMENT SHARES

1.1 General

As announced to the ASX on 11 March 2026 the Company completed a capital raising to new and existing professional and sophisticated investors, to raise approximately $2,200,000 (before costs) ( Placement ) by the issuance of 440,000,000 new shares ( Placement Shares ) via two tranches.

The Placement comprises two tranches:

• Tranche one raised $193,163 (before costs) and was made within the Company’s capacity under ASX Listing Rule 7.1 (38,632,636 Shares) (“ Tranche 1 Placement Shares ”) (“ Tranche 1 Placement ”).

• Tranche two raised $2,006,837 (before costs) and is subject to shareholder approval per Resolution 2 below (401,367,364 Shares) (“ Tranche 2 Placement Shares ”) (“ Tranche 2 Placement ”).

The Placement represented a 28.57% discount to the last closing price of the Company’s shares on 6 March 2026 and a 49.96% discount to the 15-day VWAP.

ASX Listing Rule 7.1 limits the number of equity securities that a company may issue without member approval to 15% of the issued capital of the Company in any 12-month period (subject to certain exceptions).

ASX Listing Rule 7.4 allows an issue of securities to be subsequently approved by shareholders and treated as having been made with approval of shareholders for the purpose of ASX Listing Rule 7.1. The Company is seeking subsequent shareholder approval of the issue of the Tranche 1 Placement Shares pursuant to ASX Listing Rule 7.4.

All of the Tranche 1 Placement Shares being the subject of this resolution are ordinary fully paid shares which rank equally with all of the Company’s existing ordinary fully paid shares and are quoted on the ASX. The Tranche 1 Placement Shares were issued at A$0.005 per share.

1.2 Technical Information required by Listing Rule 14.1A

If Resolution 1 is passed, the Tranche 1 Placement Shares will be excluded in calculating the Company’s 15% limit in ASX Listing Rule 7.1, effectively increasing the number of equity securities the Company can issue without Shareholder approval over the 12-month period following the date of issue of the Tranche 1 Placement Shares.

If Resolution 1 is not passed, the Tranche 1 Placement Shares will be included in calculating the Company’s 15% limit in ASX Listing Rule 7.1, effectively decreasing the number of equity securities that the Company can issue without shareholder approval over the 12-month period following the date of issue of the Tranche 1 Placement Shares.

1.3 Information required by Listing Rule 7.5

Pursuant to and in accordance with ASX Listing Rule 7.5, the following information is provided in relation to Resolution 1:

• the Tranche 1 Placement Shares were issued to professional and sophisticated investors within the meaning of sections 708(8) and 708(11) of the Corporations Act 2001 (Cth). The placement was conducted on an unbrokered basis. Recipients were identified through a bookbuild process coordinated by the

Page 7

Careteq Limited - 2026 Notice of GM

==> picture [208 x 70] intentionally omitted <==

Company, during which a number of AFSL holders were engaged to canvass expressions of interest from parties unrelated to the Company;

• The Placement participants included Sandton Capital Advisory Pty Ltd which acted as adviser to the Placement and subscribed for 1,135,518 Tranche 1 Placement Shares;

• 38,632,636 Tranche 1 Placement Shares were issued and the Tranche 1 Placement Shares issued were all fully paid ordinary shares in the capital of the Company issued under the same terms and conditions as the Company’s existing Shares;

• the Tranche 1 Placement Shares were issued 19 March 2026;

• the issue price was $0.005 per share. The Company has not and will not receive any other consideration for the issue of the Tranche 1 Placement Shares;

• the purpose of the issue was to raise capital to fund:

• Project Acquisitions;

• Debt Repayment; and

• General Working Capital Purposes.

• the Tranche 1 Placement Shares were not issued under an agreement.

1.4 Voting Exclusion Statement

In accordance with the Listing Rules, the Company will disregard any votes cast in favour of the Resolution 1 by or on behalf of a person or persons who participated in the Placement or is counterparty to the agreement being approved (namely those who participated in the Placement) or an associate if that person or those persons.

However, this does not apply to a vote cast in favour of a resolution by:

• a person as a proxy or attorney for a person who is entitled to vote on the resolution, in accordance with directions given to the proxy or attorney to vote on the resolution in that way; or

• the chair of the meeting as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with a direction given to the chair to vote on the resolution as the chair decides; or

• a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met.

• the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of the person excluded from voting, on the resolution; and

• the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

RESOLUTION 2 – APPROVAL TO ISSUE 401,367,364 TRANCHE 2 PLACEMENT SHARES

2.1 General

As noted at Resolution 1, the Company announced the Placement to the ASX on 11 March 2026, and this resolution seeks the approval from shareholders for the issue of 401,367,364 new fully paid ordinary shares in relation to the Tranche 2 Placement that raised $2,006,837 before costs (the “ Tranche 2 Placement ”).

The Placement was conducted at an issue price of A$0.005 per share, representing a 28.57% discount to the last closing price of the Company’s shares on 6 March 2026 and a 49.96% discount to the 15-day VWAP.

ASX Listing Rule 7.1 is designed to balance the Company’s interest in raising capital quickly and flexibly with the interests of existing shareholders in not having their holdings diluted without their prior approval. It does this by restricting the number of equity securities that the Company may issue without shareholder approval to a maximum of 15% of its issued share capital in any 12-month period, subject to certain exceptions.

Approval of this Resolution will have the effect that the issue of the Tranche 2 Placement Shares does not count towards the Company’s 15% placement capacity under Listing Rule 7.1 and will therefore refresh that capacity to the extent of those Shares.

All of the Tranche 2 Placement Shares being the subject of this resolution are ordinary fully paid shares which rank equally with all of the Company’s existing ordinary fully paid shares and are quoted on the ASX.

Page 8

Careteq Limited - 2026 Notice of GM

==> picture [208 x 70] intentionally omitted <==

2.2 Technical information required by Listing Rule 14.1A

If Resolution 2 is passed, the Tranche 2 Placement Shares will be excluded in calculating the Company’s 15% limit in ASX Listing Rule 7.1, effectively increasing the number of equity securities the Company can issue without Shareholder approval over the 12-month period following the date of issue of the Tranche 2 Placement Shares.

If Resolution 2 is not passed, CTQ will not be able to proceed with Tranche 2 of the placement and will not receive $2,006,837 as expected.

2.3 Information required by Listing Rule 7.3

Pursuant to and in accordance with ASX Listing Rule 7.3, the following information is provided in relation to Resolution 2:

• the Tranche 2 Placement Shares will be issued to professional and sophisticated investors within the meaning of sections 708(8) and 708(11) of the Corporations Act 2001 (Cth). The placement was conducted on an unbrokered basis. Recipients were identified through a bookbuild process coordinated by the Company, during which a number of AFSL holders were engaged to canvass expressions of interest from parties unrelated to the Company;

• The Placement participants included:

• Mr Antanas Guoga who subscribed for 3,000,000 Tranche 2 Placement Shares, decreasing his holding from 11.64% to 8.60% of the Company’s issued share capital following the Placement;

• Sandton Capital Advisory Pty Ltd which acted as adviser to the Placement and subscribed for 18,864,482 Tranche 2 Placement Shares;

• 401,367,364 Tranche 2 Placement Shares are all fully paid ordinary shares in the capital of the Company issued under the same terms and conditions as the Company’s existing Shares;

• the Tranche 2 Placement Shares will be issued no later than 3 months after the date of the meeting;

• the issue price was $0.005 per Placement Share. The Company has not and will not receive any other consideration for the issue of the Placement Shares;

• the purpose of the issue was to raise capital to fund:

• Project Acquisitions;

• Debt Repayment; and

• General Working Capital Purposes.

• the Tranche 2 Placement Shares will be not issued under an agreement.

2.4 Voting Exclusion Statement

In accordance with the Listing Rules, the Company will disregard any votes cast in favour of the Resolution 2 by or on behalf of a person or persons who participated in the Placement or is counterparty to the agreement being approved (namely those who participated in the Placement) or an associate if that person or those persons.

However, this does not apply to a vote cast in favour of a resolution by:

• a person as a proxy or attorney for a person who is entitled to vote on the resolution, in accordance with directions given to the proxy or attorney to vote on the resolution in that way; or

• the chair of the meeting as proxy or attorney for a person who is entitled to vote on the resolution, in accordance with a direction given to the chair to vote on the resolution as the chair decides; or

• a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met.

• the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of the person excluded from voting, on the resolution; and

• the holder votes on the resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

Page 9

Careteq Limited - 2026 Notice of GM

==> picture [208 x 70] intentionally omitted <==

RESOLUTION 3 – APPROVAL TO ISSUE 50,000,000 ADVISOR OPTIONS

3.1 General

As announced to the ASX on 11 March 2026 the Company completed a capital raising to new and existing professional and sophisticated investors via an Issue of Placement Shares, with Sandton Capital Advisory Pty Ltd (“Sandton”) (“ Advisor ”) acting as advisor to the Placement.

In accordance with the mandate between the Company and the Advisor, the Advisor is to receive 50,000,000 Options (“ Advisor Options ”). The Advisor Options will only be issued if shareholders approve this resolution.

ASX Listing Rule 7.1 is designed to balance the Company’s interest in raising capital quickly and flexibly with the interests of existing shareholders in not having their holdings diluted without their prior approval. It does this by restricting the number of equity securities that the Company may issue without shareholder approval to a maximum of 15% of its issued share capital in any 12-month period, subject to certain exceptions.

ASX Listing Rule 7.1 limits the number of equity securities that a company may issue without member approval to 15% of the issued capital of the Company in any 12-month period (subject to certain exceptions). As the Company does not presently have sufficient capacity under Listing Rule 7.1 to issue the Advisor Options, shareholder approval is being sought for the purposes of Listing Rule 7.1 to enable the Company to issue the Advisor Options..

3.2 Technical information required by ASX Listing Rule 14.1A

If Resolution 3 is passed, the Advisor Options will be excluded in calculating the Company’s 15% limit in ASX Listing Rules 7.1, effectively increasing the number of equity securities the Company can issue without Shareholder approval over the 12-month period following the date of issue of the Advisor Options.

If Resolution 3 is not passed, the Company will not have the capacity under ASX Listing Rule 7.1 to issue the Advisor Options. In that event, and in accordance with the terms of the mandate between the Company and the Advisor, the Company will instead pay the Advisor a cash amount equivalent to the Black-Scholes valuation of the Advisor Options as at the date of the meeting (or such other date as agreed between the Company and the Advisor). The estimated value is $77,380 of the cash amount as detailed below in paragraph 3.3.

Accordingly, shareholder approval of Resolution 3 is required to enable the Company to issue the Advisor Options under ASX Listing Rule 7.1.

3.3 Technical information required by ASX Listing Rule 7.3

Pursuant to and in accordance with ASX Listing Rule 7.3, the following information is provided in relation to Resolution 3:

• the Advisor Options will be issued to Sandton Capital Advisory Pty Ltd (“Sandton”) and/or their nominees or associates;

• 50,000,000 Advisor Options will be issued on the terms and conditions as set out in the “Terms and Conditions” below;

• the Advisor Options will be issued no later than 3 months after the date of the meeting following Shareholder approval;

• the Company has not and will not receive any other consideration for the issue of Advisor Options (other than in respect of funds received on exercise of the Advisor Options);

• the purpose of the issue of the Advisor Options was to satisfy the consideration owed to Sandton for provision of services to the Company under the mandate letter; and

• the Advisor Options will be issued under a mandate letter between the Company and the Advisor otherwise containing conventional terms to provide support for a placement to sophisticated and institutional investors, including that:

Page 10

Careteq Limited - 2026 Notice of GM

==> picture [208 x 70] intentionally omitted <==

• 50,000,000 options with a term of 2 years commencing from the date of issue and an exercise price of $0.015 are to be issued to the Advisor; and

• The Advisor Options will be split between Sandton and/or their nominees or associates.

• The value that the Company attributes to the proposed Options is based on a Black-Scholes model. The assumptions underlying the calculations are as follows:

Share price:	$0.007
Expected life:	2 Years
Risk-free rate (r):	4.830%
Expected share volatility (q):	75.00%
Dividend yield:	0%

Using the Black-Scholes method of valuation, the Company has determined a value of $77,380.

The above inputs and resultant valuation will be updated as at the date of the granting of the Options.

3.4 Terms and Conditions

The following is a summary of the key terms and conditions of the Advisor Options:

• Entitlement

• Each Advisor Option entitles the holder to subscribe for one Share upon exercise of the Advisor Option. Exercise Price

The amount payable upon exercise of each Advisor Option is $0.015.

• Vesting Date

The Advisor Options will vest immediately upon their date of issue.

Expiry Date

Each Advisor Option will expire at 5.00pm (Australian Eastern time) on the second anniversary of their date if issue. An Advisor Option not exercised before the Expiry Date will automatically lapse on Expiry Date.

Exercise Period

The Advisor Options are exercisable at any time and will expire on the Expiry Date.

Notice of Exercise

The Advisor Options may be exercised during the Exercise Period by notice in writing to the Company and payment of the Exercise Price for each Advisor Option being exercised in Australian Currency by means of payment acceptable to the Company.

Exercise Date

• A Notice of Exercise is only effective on and from the later of the date of receipt of the Notice of Exercise and the date of receipt of the payment of the Exercise Price for each Advisor Option being exercised in cleared funds.

Consideration

The Advisor Options will be issued for nil cash consideration.

Timing of Issue of Shares on Exercise

• Within 14 business days of the Exercise Date, the Company will:

• issue the number of Shares required under these terms and conditions in respect of the number of Advisor Options specified in the Notice of Exercise and for which cleared funds have been received by the Company;

• if required, give ASX a notice that complies with section 708A(5)(e) of the Corporations Act, or, if the Company is unable to issue such a notice, lodge with the ASX a prospectus prepared in accordance with the Corporations Act and do all such things necessary to satisfy section 708A(11) of the Corporations Act to ensure that an offer for sale of the Shares does not require disclosure to investors; and

Page 11

Careteq Limited - 2026 Notice of GM

==> picture [208 x 70] intentionally omitted <==

• admit the Shares to the official list of the ASX at the time and apply for quotation on ASX of Shares issued pursuant to the exercise of the Unlisted Options.

Shares Issued on Exercise

Shares issued on exercise of the Advisor Options rank equally with the then issued shares of the Company.

Reconstruction of Capital

If at any time the issued capital of the Company is reconstructed, all rights of an Optionholder are to be changed in a manner consistent with the Corporations Act and the ASX Listing Riles at the time of reconstruction.

Participation in New Shares

There are no participation rights or entitlements inherent in the Advisor Options and holders will not be entitled to participate in new shares of capital offered to Shareholders during the currency of the Advisor Options without exercising the Advisor Options.

Change in Exercise Price

• A Advisor Option does not confer the right to a change in Exercise Price or a change in the number of underlying securities over which the Advisor Option can be exercised.

Transferability

The Advisor Options are transferable subject to any restriction or escrow arrangements imposed by the ASX or under the applicable Australian securities laws.

3.5 Board Recommendation

The Board unanimously recommends that Shareholders vote in favour of this Resolution.

3.6 Voting Exclusion

The Company will disregard any votes cast in favour of Resolution 3 by or on behalf of:

• a) Sandton Capital Advisory Pty Ltd;

• b) any other person who participated in the issue or is a counterparty to the agreement being approved; or c) any Associates of those persons listed above.

However, the Company need not disregard a vote if:

• i. it is cast by a person as proxy for a person who is entitled to vote on the Resolution, in accordance with the directions on the proxy form; or

• ii. it is cast by the Chair as proxy for a person who is entitled to vote, in accordance with a direction on the proxy form to vote as the Chair decides; or

• iii. a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary provided the following conditions are met:

• the beneficiary provides written confirmation to the holder that the beneficiary is not excluded from voting, and is not an associate of a person excluded from voting, on the Resolution; and

• the holder votes on the Resolution in accordance with directions given by the beneficiary to the holder to vote in that way.

DISCLOSURE

The Company considers this Explanatory Memorandum to contain all material information known to it that could reasonably be required by Shareholders in deciding how to vote on the proposed Resolutions other than information that would be unreasonable to require the Company to disclose because it has previously disclosed that information to Shareholders.

Page 12

Careteq Limited - 2026 Notice of GM

==> picture [208 x 70] intentionally omitted <==

GLOSSARY

$ means Australian dollars.

AEDT means Australian Eastern Daylight Time as observed in Melbourne, Victoria.

AEST means Australian Eastern Standard Time as observed in Melbourne, Victoria.

General Meeting or Meeting or GM means the meeting convened by the Notice.

Annual Financial Report means the 2025 annual report of the Company containing the financial report for the period ended 30 June 2025, a copy of which was lodged by the Company by way of Appendix 4E with ASX on 30 September 2025.

Associate has the meaning given to it in the Corporations Act.

ASX Listing Rules or Listing Rules means the Listing Rules of ASX and any other rules of the ASX which are applicable while the Company is admitted to the official list of the ASX, as amended or replaced from time to time, except to the extent of any express written waiver by the ASX.

Auditor’s Report means the auditor’s report of RSM Australia Partners dated 30 September 2025 as included in the Annual Financial Report.

ASX means ASX Limited (ACN 008 624 691) or the financial market operated by ASX Limited, as the context requires.

Automic means Automic Registry Services, being the share register for the Company.

Board means the current board of directors of the Company.

Business Day means a day on which trading takes place on the stock market of ASX.

Chair means the chair of the Meeting.

Closely Related Party of a member of Key Management Personnel means:

• a) a spouse or child of the member;

• b) a child of the member’s spouse;

• c) a dependent of the member or the member’s spouse;

• d) anyone else who is one of the member’s family and may be expected to influence the member, or be

influenced by the member, in the member’s dealing with the entity;

• e) a company the member controls; or

• f) a person prescribed by the Corporations Act 2001 (Cth) for the purposes of the definition of ‘closely

related party’ in the Corporations Act.

Company means Careteq Limited (ACN 612 267 857).

Constitution means the Company’s constitution.

Corporations Act means the Corporations Act 2001 (Cth) as amended or replaced from time to time.

Director means a current director of the Company.

Page 13

Careteq Limited - 2026 Notice of GM

==> picture [208 x 70] intentionally omitted <==

Equity Securities includes a Share, a right to a Share or Option, an Option, a convertible security and any security that ASX decides to classify as an Equity Security.

Explanatory Memorandum mean the explanatory memorandum accompanying this Notice.

Key Management Personnel or KMP means key management personnel (including the Directors) whose remuneration details are included in the Remuneration Report.

Notice of General Meeting or Notice of Meeting or Notice means this notice of meeting including the Explanatory Memorandum and the Proxy Form.

Option means an option to acquire a Share.

Ordinary Resolution means a resolution that can only be passed if at least 50% of the total votes cast by Shareholders entitled to vote on the resolution are voted in its favour at the meeting.

Proxy Form means the proxy form accompanying the Notice.

Remuneration Report means the remuneration report as set out in the Annual Financial Report.

Relevant Interest has the meaning given to it in the Corporations Act.

Resolutions means the resolutions set out in the Notice, or any one of them, as the context requires.

Share means a fully paid ordinary share in the capital of the Company.

Shareholder means a registered holder of a Share.

Special Resolution means a resolution that can only be passed if at least 75% of the total votes cast by Shareholders entitled to vote on the resolution are voted in its favour at the meeting.

Variable A means “A” as set out in the formula in ASX Listing Rule 7.1A.2.

Page 14

Careteq Limited - 2026 Notice of GM

Careteq Limited | ABN 83 612 267 857

==> picture [171 x 58] intentionally omitted <==

Proxy Voting Form If you are attending the virtual Meeting please retain this Proxy Voting Form for online Securityholder registration.

Your proxy voting instruction must be received by 9:00am (AEST) on Tuesday, 21 April 2026 , being not later than 48 hours before the commencement of the Meeting. Any Proxy Voting instructions received after that time will not be valid for the scheduled Meeting.

SUBMIT YOUR PROXY

Complete the form overleaf in accordance with the instructions set out below.	Lodging your Proxy Voting Form:
YOUR NAME AND ADDRESS The name and address shown above is as it appears on the Company’s share register. If this information is incorrect, and you have an Issuer Sponsored holding, you can update your address through the investor portal:https://investor.automic.com.au/#/homeShareholders sponsored by a broker should advise their broker of any changes.	Online Use your computer or smartphone to appoint a proxy at https://investor.automic.com.au/#/loginsahor scan the QR code below using your
STEP 1 - APPOINT A PROXY	smartphone
If you wish to appoint someone other than the Chair of the Meeting as your proxy, please write the name of	Login & Click on ‘Meetings’. Use the
that Individual or body corporate. A proxy need not be a Shareholder of the Company. Otherwise if you	Holder Number as shown at the top of
leave this box blank, the Chair of the Meeting will be appointed as your proxy by default.	this Proxy Voting Form.
DEFAULT TO THE CHAIR OF THE MEETING
Any directed proxies that are not voted on a poll at the Meeting will default to the Chair of the Meeting,
who is required to vote these proxies as directed. Any undirected proxies that default to the Chair of the
Meeting will be voted according to the instructions set out in this Proxy Voting Form, including where the
Resolutions are connected directly or indirectly with the remuneration of Key Management Personnel.

STEP 2 - VOTES ON ITEMS OF BUSINESS

You may direct your proxy how to vote by marking one of the boxes opposite each item of business. All your shares will be voted in accordance with such a direction unless you indicate only a portion of voting rights are to be voted on any item by inserting the percentage or number of shares you wish to vote in the appropriate box or boxes. If you do not mark any of the boxes on the items of business, your proxy may vote as he or she chooses. If you mark more than one box on an item your vote on that item will be invalid.

APPOINTMENT OF SECOND PROXY

You may appoint up to two proxies. If you appoint two proxies, you should complete two separate Proxy Voting Forms and specify the percentage or number each proxy may exercise. If you do not specify a percentage or number, each proxy may exercise half the votes. You must return both Proxy Voting Forms together. If you require an additional Proxy Voting Form, contact Automic Registry Services.

SIGNING INSTRUCTIONS

Individual: Where the holding is in one name, the Shareholder must sign. Joint holding: Where the holding is in more than one name, all Shareholders should sign. Power of attorney: If you have not already lodged the power of attorney with the registry, please attach a certified photocopy of the power of attorney to this Proxy Voting Form when you return it. Companies: To be signed in accordance with your Constitution. Please sign in the appropriate box which indicates the office held by you. Email Address: Please provide your email address in the space provided. By providing your email address, you elect to receive all communications despatched by the Company electronically (where legally permissible) such as a Notice of Meeting, Proxy Voting Form and Annual Report via email.

CORPORATE REPRESENTATIVES

If a representative of the corporation is to attend the Meeting the appropriate ‘Appointment of Corporate Representative’ should be produced prior to admission. A form may be obtained from the Company’s share registry online at https://automicgroup.com.au.

BY MAIL: Automic GPO Box 5193 Sydney NSW 2001

IN PERSON:

Automic Level 5, 126 Phillip Street Sydney NSW 2000

BY EMAIL:

meetings@automicgroup.com.au

BY FACSIMILE:

+61 2 8583 3040

All enquiries to Automic: WEBSITE: https://automicgroup.com.au

PHONE:

1300 288 664 (Within Australia) +61 2 9698 5414 (Overseas)

STEP 1 - How to vote

APPOINT A PROXY:

I/We being a Shareholder entitled to attend and vote at the Annual General Meeting of Careteq Limited, to be held virtually at 9:00am (AEST) on Thursday, 23 April 2026 hereby:

Appoint the Chair of the Meeting (Chair) to vote in accordance with the following directions (or if no directions have been given, and subject to the relevant laws, as the Chair sees fit) at this meeting and at any adjournment thereof.

Please note: If you are not appointing the Chair of the Meeting as your proxy, please write in the box provided below the name of the person or body corporate you are appointing as your proxy. If the person so named is absent from the meeting, or if no person is named, the Chair will act on your behalf.

The Chair intends to vote undirected proxies in favour of all Resolutions in which the Chair is

entitled to vote.

Unless indicated otherwise by marking the “for”, “against” or “abstain” box you will be authorising the Chair to vote in accordance with the Chair’s voting intention.

VIRTUAL PARTICIPATION AT THE MEETING:

The Company is pleased to provide

==> picture [37 x 172] intentionally omitted <==

shareholders with the opportunity to attend and participate in a virtual Meeting through an online meeting platform powered by Automic, where shareholders will be able to watch, listen, and vote online.

To access the virtual meeting:

1. Open your internet browser and go to investor.automic.com.au

2. Login with your username and password or click “register” if you haven’t already created an account. Shareholders are encouraged to create an account prior to the start of the meeting to ensure there is no delay in attending the virtual meeting

Further information on how to do this is set out in the Notice of Meeting. The Explanatory Notes that accompany and form part of the Notice of Meeting describe the various matters to be considered.

STEP 2 - Your voting direction

Resolutions	For	Against Abstain	Against Abstain
1 RATIFICATION OF PRIOR ISSUE OF 38,632,636 TRANCHE 1 PLACEMENT SHARES
2 APPROVAL TO ISSUE 401,367,364 TRANCHE 2 PLACEMENT SHARES
3 APPROVAL TO ISSUE 50,000,000 ADVISOR OPTIONS
Please note:If you mark the abstain box for a particular Resolution, you are directing your proxy not to vote on that Resolution and your votes will not
be counted in computing the required majority on a poll.

STEP 3	STEP 3	STEP 3	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details	– Signatures and contact details
		Individual					or Securityholder 1																	Securityholder 2														Securityholder 3
	Sole Director and Sole Company Secretary																								Director										Director / Company Secretary
Contact Name:
Email		Address:
Contact Daytime Telephone																														Date (DD/MM/YY)
																																			/						/
By providing			your		email address, you elect to												receive all					communications despatched by the Company electronically (where legally permissible).